NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Free peptide testing

Ordered peptides from Polaris Peptides? Mail in a sample (US only) and let us test it.

Test my supply
+1 more ↓
63%
Finnrick rating
#359 of 457 ranked vendors
66 of 99 classifiable tests passed
methodology · Purity focus
Finnrick analysis

Polaris Peptides' stronger purity-focus evidence sits in Tirzepatide and improving Retatrutide after earlier purity misses. The record is dispersed rather than uniform: BPC-157 has repeated recent purity failures, GHK-Cu shows fill overages, and some otherwise current, high-volume evidence lacks batch IDs.

methodology →
vendor intelligence report
Vendor Intelligence Report: Polaris Peptides

We investigated who actually operates Polaris Peptides — corporate records, ownership trails, web infrastructure, and how its lab results break down product by product. Read the full report before you order.

28 pages8 risk factors assessed12 Jun 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.63
82%
5
2
Tirzepatide
$9.90
80%
16
3
Retatrutide
$11.90
78%
29
4
Mazdutide
$15.00
69%
3
5
Semaglutide
$9.35
68%
19
6
PT-141
$3.40
65%
8
7
Survodutide
$12.75
52%
6
8
BPC-157
$5.40
35%
17
9
CJC-1295
$5.40
32%
4
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%11 Aug 2025: 66%11 Aug 2025: 67%11 Aug 2025: 66%11 Aug 2025: 65%11 Aug 2025: 65%11 Aug 2025: 66%11 Aug 2025: 66%11 Aug 2025: 66%12 Aug 2025: 65%12 Aug 2025: 65%12 Aug 2025: 65%12 Aug 2025: 66%12 Aug 2025: 66%12 Aug 2025: 65%12 Aug 2025: 65%12 Aug 2025: 65%12 Aug 2025: 65%15 Aug 2025: 65%15 Aug 2025: 64%19 Aug 2025: 65%19 Aug 2025: 65%19 Aug 2025: 65%19 Aug 2025: 65%1 Oct 2025: 65%1 Oct 2025: 64%9 Oct 2025: 65%7 Nov 2025: 65%25 Nov 2025: 64%7 Jan 2026: 64%19 Jan 2026: 64%13 May 2026: 65%13 May 2026: 65%9 Aug 2026: 65%9 Aug 2026: 65%9 Aug 2026: 64%9 Aug 2026: 64%15 Sep 2026: 64%15 Sep 2026: 64%16 Sep 2026: 63%16 Sep 2026: 63%8 Oct 2026: current 63%66%64%63%Aug 25Oct 26
Free peptide testing

Ordered peptides from Polaris Peptides? Mail in a sample (US only) and let us test it.

Test my supply
Polaris Peptides test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
16 Sep 2026
Fail
BPC-157
lab nameView COA
16 Sep 2026
Fail
Tirzepatide
lab nameView COA
15 Sep 2026
Pass
GHK-Cu
lab nameView COA
15 Sep 2026
Fail
BPC-157
lab nameView COA
9 Aug 2026
Fail
BPC-157
lab nameView COA
9 Aug 2026
Pass
BPC-157
lab nameView COA
9 Aug 2026
Fail
Semaglutide
lab nameView COA
9 Aug 2026
Fail
Semaglutide
lab nameView COA
13 May 2026
Pass
Retatrutide
lab nameView COA
13 May 2026
Fail
BPC-157
lab nameView COA
1-10 of 107

About Polaris Peptides test results from Finnrick

Polaris Peptides is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 9 peptides and 107 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Polaris Peptides peptides in this dataset are BPC-157 (17 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 107 recent tests.

Corrections
No corrections.
Free peptide testing

Ordered peptides from Polaris Peptides? Mail in a sample (US only) and let us test it.

Test my supply